As an immunocompromised group, XLA patients must be well educated on COVID-19. This is a place built to provide up-to-date COVID-19 resources specifically for the XLA family.
SARS-CoV-2 Specific Antibodies in IgG Products
Because XLA patients do not create their own antibodies, we rely on blood/plasma donations from everyone for antibodies. That means we also do not create our own antibodies after vaccination. Thankfully, SARS-CoV-2 specific antibodies have been identified in IgG products. We will compile sources and updated information as more studies come out.
If you have recently been vaccinated, please consider donating blood or plasma ~3 weeks after vaccination.
XLA, COVID vaccines, and clinical trials
Help science learn more about immune deficiencies. Many institutes are looking for immune deficient patients (and healthy volunteers) to participate in COVID-19 vaccine trials. Check out the links below!
Duke Health: https://www.dukehealth.org/clinical-trials/directory/pro00108422
Disclaimer: The opinions expressed on this site and by XLA Life Corp. do not represent those of the federal government, the National Institutes of Health, any other institutes mention, or study personnel.